Abacavir/dolutegravir/lamivudine fixed-dose combination tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Abacavir/dolutegravir/lamivudine fixed-dose combination tablet, covering 2015-12-21 to 2015-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects [Phase 1]